Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Locally Aggressive Breast Desmoid Fibromatosis in a Young Woman With Multiple Fibroadenomas.

Created on 09 Oct 2026

Authors

Marilin Rosa

Published in

International journal of surgical pathology. Pages 10668969261482140. Oct 09, 2026. Epub Oct 09, 2026.

Abstract

Desmoid fibromatosis is a rare spindle cell neoplasm with fibroblastic/myofibroblastic differentiation, accounting for less than 0.2% of all breast tumors. It affects predominantly women and although can be locally aggressive, it has no metastatic potential. Diagnosis requires tissue sampling, correlation with imaging and clinical findings, and the use of ancillary studies. Breast fibromatosis typically exhibits nuclear β-catenin positivity, with variable expression of smooth muscle actin (SMA), desmin, and calponin, but is generally negative for h-caldesmon-a marker traditionally considered helpful in distinguishing fibromatosis from tumors with true smooth muscle differentiation. A 22-year-old woman presented with a left breast mass initially diagnosed as fibroadenoma on biopsy. Surgical excision revealed bland spindle cells within a collagenous stroma and infiltrative borders. Immunohistochemistry demonstrated positivity for h-caldesmon, nuclear β-catenin, and calponin. Molecular analysis confirmed an activating CTNNB1 mutation, establishing the diagnosis of fibromatosis.

PMID:
42852825
Bibliographic data and abstract were imported from PubMed on 09 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement